Collaboration Provides New Tools for Liver Cancer Treatment
By MedImaging International staff writers Posted on 21 Feb 2016 |
Image: Treating a liver cancer patient using live image-guidance and radiopaque embolic beads (Photo courtesy of Philips Healthcare).
Interventional radiologists and oncologists have for the first time treated a liver cancer patient using a new procedure that aims to block blood flow and achieve tumor necrosis.
The procedure is the result of collaboration between two specialist healthcare manufacturers, and uses live image-guidance to visualize embolic beads during treatment of liver cancer. Liver cancer is difficult to treat, and is a leading cause of death from cancer worldwide. The procedure can help those patients with liver cancer tumors that cannot be removed using surgery.
BTG (London, UK) and Royal Philips (Amsterdam, the Netherlands) developed the intervention which used BTG's LC Bead LUMI radiopaque embolic bead, and Philips' 2-D X-Ray and 3-D Cone-Beam Computed Tomography (CBCT) image guidance. The procedure enables interventional radiologists and oncologists to see whether tumor treatment is complete, by providing live enhanced visualization.
Ronald Tabaksblat, business leader of Philips' Image Guided Therapy Systems, said, "Minimally-invasive therapy procedures provide key benefits for healthcare systems and patients, and intelligent image guidance is an essential part of these procedures. We aim to continuously improve Image Guided Therapy and our collaboration with BTG to provide enhanced visibility and guidance during interventional embolization procedures is another important milestone in this exciting journey to help deliver excellent treatment and enhanced patient care."
Related Links:
Philips
The procedure is the result of collaboration between two specialist healthcare manufacturers, and uses live image-guidance to visualize embolic beads during treatment of liver cancer. Liver cancer is difficult to treat, and is a leading cause of death from cancer worldwide. The procedure can help those patients with liver cancer tumors that cannot be removed using surgery.
BTG (London, UK) and Royal Philips (Amsterdam, the Netherlands) developed the intervention which used BTG's LC Bead LUMI radiopaque embolic bead, and Philips' 2-D X-Ray and 3-D Cone-Beam Computed Tomography (CBCT) image guidance. The procedure enables interventional radiologists and oncologists to see whether tumor treatment is complete, by providing live enhanced visualization.
Ronald Tabaksblat, business leader of Philips' Image Guided Therapy Systems, said, "Minimally-invasive therapy procedures provide key benefits for healthcare systems and patients, and intelligent image guidance is an essential part of these procedures. We aim to continuously improve Image Guided Therapy and our collaboration with BTG to provide enhanced visibility and guidance during interventional embolization procedures is another important milestone in this exciting journey to help deliver excellent treatment and enhanced patient care."
Related Links:
Philips
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment